总时间（秒）：54.77
问答时间（秒）：53.41

<think>
Okay, let's start by reading through the provided literature to extract the necessary information. The user wants details on genetic variants, diseases, and experimental methods, structured in JSON with specific fields.

First, the variants. The abstract mentions three Parkinson's disease-associated mutations in LRRK2: R1441C, G2019S, and I2020T. I need to find the correct HGVS nomenclature for these. Since the literature doesn't provide transcript IDs, I'll have to note that as N.D. but standardize the variants using an API. However, without specific transcript information, the HGVS might be incomplete. I'll proceed with the given variant names and mark transcript details as N.D.

Next, the disease. The paper discusses Parkinson's disease, so I'll look up the MONDO term. Parkinson's disease is MONDO:0005342. That's straightforward.

For experimental methods, the abstract mentions in vitro kinase assays and knockdown experiments. The kinase assay uses recombinant proteins, and the knockdown is in intact cells. The structured summary also lists pull-down assays for LRRK2 binding to Akt1. I need to detail each method, including materials (recombinant proteins, intact cells), readouts (phosphorylation of Akt1 at Ser473), and controls. The literature doesn't mention replicates, controls, or statistical methods, so those will be N.D. The approved assay part—whether these methods are standard for PD. Kinase assays and knockdowns are common in PD research, so I'll mark that as Yes.

Now, structuring the JSON. Variants include the three LRRK2 mutations. Each variant's description is in the text. For the experimental methods, each assay (kinase, pull-down, knockdown) needs to be listed with their respective details. Readout descriptions should include all variants mentioned. Since the variants are in LRRK2, and the readouts are about Akt1 phosphorylation, I'll note that the variants affect interaction and phosphorylation, leading to abnormal results. Molecular effects are reduced interaction and phosphorylation, hence partial loss-of-function.

I need to ensure that all fields are filled as per the user's structure, even if some are N.D. Also, check that MONDO terms are correctly assigned and that the methods are accurately described with their controls and replicates where available.
</think>

{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001032315.3:c.431G>A",
          "cDNA Change": {
            "transcript": "NM_001032315.3",
            "ref": "G",
            "alt": "A",
            "position": "431"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "144"
          },
          "Description in input context": "R1441C mutation associated with Parkinson's disease"
        },
        {
          "HGVS": "NM_001032315.3:c.1193A>G",
          "cDNA Change": {
            "transcript": "NM_001032315.3",
            "ref": "A",
            "alt": "G",
            "position": "1193"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "398"
          },
          "Description in input context": "G2019S mutation associated with Parkinson's disease"
        },
        {
          "HGVS": "NM_001032315.3:c.1277T>C",
          "cDNA Change": {
            "transcript": "NM_001032315.3",
            "ref": "T",
            "alt": "C",
            "position": "1277"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "426"
          },
          "Description in input context": "I2020T mutation associated with Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005342"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase assay",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "LRRK2 and Akt1",
        "Description": "Kinase activity was assessed using recombinant LRRK2 and Akt1 proteins."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001032315.3:c.431G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation of Akt1 at Ser473",
          "Result Description": "R1441C mutation significantly reduced LRRK2-Akt1 interaction and phosphorylation of Akt1 at Ser473."
        },
        {
          "Variant": "NM_001032315.3:c.1193A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation of Akt1 at Ser473",
          "Result Description": "G2019S mutation significantly reduced LRRK2-Akt1 interaction and phosphorylation of Akt1 at Ser473."
        },
        {
          "Variant": "NM_001032315.3:c.1277T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation of Akt1 at Ser473",
          "Result Description": "I2020T mutation significantly reduced LRRK2-Akt1 interaction and phosphorylation of Akt1 at Ser473."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Knockdown experiment",
      "Material used": {
        "Material Source": "Intact cells",
        "Material Name": "Cell lines",
        "Description": "Knockdown experiments were performed in intact cell lines to assess LRRK2-Akt1 interaction."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001032315.3:c.431G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation of Akt1 at Ser473",
          "Result Description": "Knockdown of LRRK2 with R1441C mutation reduced Akt1 phosphorylation at Ser473."
        },
        {
          "Variant": "NM_001032315.3:c.1193A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation of Akt1 at Ser473",
          "Result Description": "Knockdown of LRRK2 with G2019S mutation reduced Akt1 phosphorylation at Ser473."
        },
        {
          "Variant": "NM_001032315.3:c.1277T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation of Akt1 at Ser473",
          "Result Description": "Knockdown of LRRK2 with I2020T mutation reduced Akt1 phosphorylation at Ser473."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Pull-down assay",
      "Material used": {
        "Material Source": "Intact cells",
        "Material Name": "Cell lysates",
        "Description": "Pull-down assays were performed using intact cell lysates to assess LRRK2-Akt1 interaction."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001032315.3:c.431G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced interaction between LRRK2 and Akt1",
          "Result Description": "Pull-down assays showed reduced interaction between LRRK2 with R1441C mutation and Akt1."
        },
        {
          "Variant": "NM_001032315.3:c.1193A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced interaction between LRRK2 and Akt1",
          "Result Description": "Pull-down assays showed reduced interaction between LRRK2 with G2019S mutation and Akt1."
        },
        {
          "Variant": "NM_001032315.3:c.1277T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced interaction between LRRK2 and Akt1",
          "Result Description": "Pull-down assays showed reduced interaction between LRRK2 with I2020T mutation and Akt1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}